JPS58103312A - 難溶性医薬品の注射剤用水溶液 - Google Patents

難溶性医薬品の注射剤用水溶液

Info

Publication number
JPS58103312A
JPS58103312A JP56201934A JP20193481A JPS58103312A JP S58103312 A JPS58103312 A JP S58103312A JP 56201934 A JP56201934 A JP 56201934A JP 20193481 A JP20193481 A JP 20193481A JP S58103312 A JPS58103312 A JP S58103312A
Authority
JP
Japan
Prior art keywords
injection
acid
aqueous solution
aspartic acid
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56201934A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6365047B2 (ko
Inventor
Norio Nakajima
規夫 中島
Yoshimasa Zaishiyo
税所　宣誠
Masayoshi Ariga
有賀　政義
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Priority to JP56201934A priority Critical patent/JPS58103312A/ja
Priority to PT75985A priority patent/PT75985B/pt
Priority to CA000417637A priority patent/CA1184495A/en
Priority to ES518199A priority patent/ES8405613A1/es
Priority to GR70069A priority patent/GR77823B/el
Priority to KR8205621A priority patent/KR880001632B1/ko
Priority to MX82101115U priority patent/MX7581E/es
Publication of JPS58103312A publication Critical patent/JPS58103312A/ja
Publication of JPS6365047B2 publication Critical patent/JPS6365047B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP56201934A 1981-12-15 1981-12-15 難溶性医薬品の注射剤用水溶液 Granted JPS58103312A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP56201934A JPS58103312A (ja) 1981-12-15 1981-12-15 難溶性医薬品の注射剤用水溶液
PT75985A PT75985B (en) 1981-12-15 1982-12-14 Process to produce a pharmaceutical composition of famotidine for injection
CA000417637A CA1184495A (en) 1981-12-15 1982-12-14 Process of producing pharmaceutical composition of famotidine for injection
ES518199A ES8405613A1 (es) 1981-12-15 1982-12-14 Un procedimiento para producir una composicion inyectable acuosa de famotidina.
GR70069A GR77823B (ko) 1981-12-15 1982-12-14
KR8205621A KR880001632B1 (en) 1981-12-15 1982-12-15 Process for preparing famotidino injection composition
MX82101115U MX7581E (es) 1981-12-15 1982-12-15 Procedimiento para preparar una composicion farmaceutica a base de famotidina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56201934A JPS58103312A (ja) 1981-12-15 1981-12-15 難溶性医薬品の注射剤用水溶液

Publications (2)

Publication Number Publication Date
JPS58103312A true JPS58103312A (ja) 1983-06-20
JPS6365047B2 JPS6365047B2 (ko) 1988-12-14

Family

ID=16449204

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56201934A Granted JPS58103312A (ja) 1981-12-15 1981-12-15 難溶性医薬品の注射剤用水溶液

Country Status (7)

Country Link
JP (1) JPS58103312A (ko)
KR (1) KR880001632B1 (ko)
CA (1) CA1184495A (ko)
ES (1) ES8405613A1 (ko)
GR (1) GR77823B (ko)
MX (1) MX7581E (ko)
PT (1) PT75985B (ko)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749790A (en) * 1985-06-28 1988-06-07 Barisintex, S.A Process for preparing H2 receptor antagonist ascorbate compounds
WO2002041892A1 (fr) * 2000-11-24 2002-05-30 Yamanouchi Pharmaceutical Co., Ltd. Liquide hydrosoluble pour medecine interne
WO2003055483A1 (fr) * 2001-12-27 2003-07-10 Terumo Kabushiki Kaisha Solution d'injection de famotidine
WO2003094889A1 (fr) * 2002-05-13 2003-11-20 Daiichi Pharmaceutical Co., Ltd. Produit de lyophilisation

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1352654E (pt) 2000-12-22 2006-06-30 Astellas Pharma Inc Injeccoes de famotidina.
JP4828040B2 (ja) * 2001-04-27 2011-11-30 テルモ株式会社 ファモチジン注射液
CN111904936B (zh) * 2020-08-28 2022-07-19 开封康诺药业有限公司 一种法莫替丁冻干粉针剂
CN114681409A (zh) * 2021-10-20 2022-07-01 海南倍特药业有限公司 一种注射用法莫替丁及其制备方法
CN114028342B (zh) * 2021-12-08 2023-04-28 广东彼迪药业有限公司 一种法莫替丁速崩颗粒、法莫替丁片及制备方法

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749790A (en) * 1985-06-28 1988-06-07 Barisintex, S.A Process for preparing H2 receptor antagonist ascorbate compounds
WO2002041892A1 (fr) * 2000-11-24 2002-05-30 Yamanouchi Pharmaceutical Co., Ltd. Liquide hydrosoluble pour medecine interne
WO2003055483A1 (fr) * 2001-12-27 2003-07-10 Terumo Kabushiki Kaisha Solution d'injection de famotidine
WO2003094889A1 (fr) * 2002-05-13 2003-11-20 Daiichi Pharmaceutical Co., Ltd. Produit de lyophilisation

Also Published As

Publication number Publication date
PT75985A (en) 1983-01-01
PT75985B (en) 1985-12-05
GR77823B (ko) 1984-09-25
CA1184495A (en) 1985-03-26
ES518199A0 (es) 1984-06-16
JPS6365047B2 (ko) 1988-12-14
MX7581E (es) 1989-11-24
ES8405613A1 (es) 1984-06-16
KR840002654A (ko) 1984-07-16
KR880001632B1 (en) 1988-09-03

Similar Documents

Publication Publication Date Title
TW442295B (en) Stable freeze-dried pharmaceutical composition
JPS6191116A (ja) 安定化された注射用ピロキシカム液剤
JPS6094910A (ja) ピペラジニル―キノロンカルボン酸の乳酸塩の溶液
JPS58103312A (ja) 難溶性医薬品の注射剤用水溶液
JP4543679B2 (ja) 唯一の共同溶剤としてプロピレングリコールを含んでいる使用準備ができているパラセタモール注射溶液
EP2131845A1 (en) Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms
US20080233196A1 (en) Injectable sterile pharmaceutical composition with piperacillin sodium and tazobactam sodium as active principles
JPH07173058A (ja) 消炎鎮痛ゲル製剤
JPH0131390B2 (ko)
JPH07503941A (ja) スパルフロキサシンの溶液、その調製及びそれから成る塩
NO153916B (no) Fremgangsmaate for fremstilling av en stabil, injiserbar opploesning av et oksytetracyklin-chelat.
JP3213283B2 (ja) 注射剤
RU2241488C1 (ru) Раствор даларгина для инъекций
CA1170571A (en) Pharmaceutical compositions
JP2635009B2 (ja) 安定なエルカトニン製剤
JP2001519390A (ja) 安定剤としてグリシンを含む製薬学的製剤
AU670838B2 (en) Soluble calcium lactate/quindonecarboxylic acids on naphthydrinecarboxylic acids complexes as non-irritating parenteral forms
KR920006911B1 (ko) 안정한 피록시캄 주사액 조성물 및 그의 제조방법
JP4296374B2 (ja) 安定な液状製剤
KR930001302B1 (ko) 시플로플록사신의 주사용 조성물 및 그 제조방법
JPH11193234A (ja) ニカルジピンの液状医薬品製剤
JPH0390019A (ja) 製薬学的活性物質の非経口的投与可能な溶液の調製方法
JPH0118051B2 (ko)
JP4193218B2 (ja) ビオチンの溶解方法及びビオチン含有内服液剤
JPH10298102A (ja) カルシトニン注射液